dc.contributor.author | Guo, Hua | |
dc.contributor.author | Chen, Nandi | |
dc.contributor.author | Harmsen, Stefan | |
dc.contributor.author | SÖNMEZOĞLU, Kerim | |
dc.contributor.author | Lundon, Dara J. | |
dc.contributor.author | Oklu, Rahmi | |
dc.contributor.author | Ting, Richard | |
dc.contributor.author | Tewari, Ashutosh | |
dc.contributor.author | Akin, Oguz | |
dc.contributor.author | SAYMAN, Haluk Burcak | |
dc.contributor.author | Aras, Omer | |
dc.contributor.author | DEMİRDAĞ, Çetin | |
dc.contributor.author | Kommidi, Harikrishna | |
dc.contributor.author | Pavlova, Ina | |
dc.contributor.author | AYGÜN, Aslan | |
dc.contributor.author | KARAYEL, Emre | |
dc.contributor.author | Pehlivanoglu, Huseyin | |
dc.contributor.author | YEYİN, Nami | |
dc.contributor.author | Kyprianou, Natasha | |
dc.date.accessioned | 2021-12-10T09:57:00Z | |
dc.date.available | 2021-12-10T09:57:00Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Aras O., DEMİRDAĞ Ç., Kommidi H., Guo H., Pavlova I., AYGÜN A., KARAYEL E., Pehlivanoglu H., YEYİN N., Kyprianou N., et al., "Small Molecule, Multimodal, [F-18]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study", CLINICAL GENITOURINARY CANCER, cilt.19, sa.5, ss.405-416, 2021 | |
dc.identifier.issn | 1558-7673 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_1e2b21e7-4326-40f3-8ea1-f5168fcab703 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/168844 | |
dc.identifier.uri | https://doi.org/10.1016/j.clgc.2021.03.011 | |
dc.description.abstract | A number of radioactive tracers are currently being actively examined to image prostate-specific membrane antigen positive (PSMA+) tumors, especially in primary and recurrent prostate cancer. We report a first-in-human study of [18F]-BF3-Cy3-ACUPA by determining its safety, biodistribution, radiation dosimetry, and feasibility of tumor detection by preoperative positron emission tomography, as well as intraoperative fluorescence imaging, in patients with PSMA+ tumors. | |
dc.language.iso | eng | |
dc.subject | Onkoloji | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | ÜROLOJİ VE NEFROLOJİ | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Nefroloji | |
dc.subject | Nephrology | |
dc.subject | Oncology | |
dc.subject | Urology | |
dc.subject | Health Sciences | |
dc.title | Small Molecule, Multimodal, [F-18]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study | |
dc.type | Makale | |
dc.relation.journal | CLINICAL GENITOURINARY CANCER | |
dc.contributor.department | Mem Sloan Kettering Canc Ctr , , | |
dc.identifier.volume | 19 | |
dc.identifier.issue | 5 | |
dc.identifier.startpage | 405 | |
dc.identifier.endpage | 416 | |
dc.contributor.firstauthorID | 2755914 | |